INDOCO258.00

Indoco Remedies Limited

· Pharma & Health
AnnualQuarterly₹ CrorePeersSAIPARENTPANACEABIOHIKALWINDLASHESTERBIODCALSYNCOMFSOLARAMcap ₹2,381 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations1,817.31,664.91,845.31,873.1
Other Income9.95.53.33.9
Total Income1,827.11,670.41,848.71,877.0
Expenses
+ Cost of Materials Consumed485.0396.3425.6424.6
+ Purchases of Stock-in-Trade115.7140.9143.6144.2
+ Changes in Inventories-41.5-39.0-27.4-4.0
+ Employee Benefit Expense361.9394.1425.7420.1
+ Finance Costs38.066.2122.3124.4
+ Depreciation & Amortisation91.9113.8126.5131.3
+ Other Expenses651.9673.4736.1723.0
Total Expenses1,702.91,745.71,952.21,963.5
EBITDA244.399.3141.8165.3
EBIT152.4-14.615.434.0
Profit
PBT before Exceptional Items124.3-75.4-103.6-86.5
+ Exceptional Items11.51.0-2.994.4
Pretax Income135.8-74.4-106.57.9
+ Current Tax33.20.53.013.6
+ Deferred Tax5.63.1-10.8-8.8
Tax Expense38.83.6-7.84.8
Net Income97.0-78.0-98.73.1
+ Net Income — Continuing Ops97.0-78.0-98.73.1
+ Other Comprehensive Income0.3-4.112.613.4
Total Comprehensive Income97.3-82.1-86.116.5
Net Income to Common98.5-73.7-95.25.6
Minority Interest-1.5-4.2-3.6-2.5
Per Share
Basic EPS10.538.46-10.700.32
Diluted EPS10.518.45-10.690.34
Other Comprehensive Income — detail
+ Other Comprehensive Income-4.112.613.4
+ Items NOT to be Reclassified to P&L0.1-6.01.82.0
+ Tax on Items NOT to be Reclassified-1.50.50.5
+ Tax on Items NOT to be Reclassified — alt tag0.0
+ Items to be Reclassified to P&L0.20.312.612.9
+ Tax on Items to be Reclassified-0.11.41.0
Comprehensive Income — Owners of Parent98.7-77.9-82.519.1
Comprehensive Income — Non-controlling Interests-1.5-4.2-3.6-2.5
Per Share — as-filed variants
Basic EPS — Continuing Operations10.538.46-10.700.32
Diluted EPS — Continuing Operations10.518.45-10.690.34
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit1,258.11,166.71,303.61,308.3
Gross Margin %69.2370.0870.6469.85
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)124.3-75.4-103.6-86.5
− Exceptional Items (reconciliation)11.51.0-2.994.4
Net Income Adj (tax-effected)88.8-78.9-96.0-34.7
EPS Adj9.648.57-10.40-3.58
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value2.002.002.002.00
Paid Up Equity Capital18.418.518.518.5
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.